Internal Medicine, Hematology & Oncology · Baton Rouge, LA
NPI
1841634011
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
8585 Picardy Ave Ste 110
Baton Rouge, LA, 70809
Phone (225) 767-0822
Medicare paid, 2024
$68K
9,276 services
Medicare patients, 2024
108
Average age 73
Drug cost, 2024
$2.5M
630 prescriptions
Company payments, 2025
$43K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sanjay K Juneja was code 99215 (office e&m - established), 126 times for 36 patients. In total Sanjay K Juneja billed 9,276 services in 27 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 126 | 36 | $126.54 | $16K |
| 99214 Office E&M - Established | Office | 116 | 58 | $88.95 | $10K |
| 99213 Office E&M - Established | Office | 51 | 42 | $52.91 | $2,698 |
| 99212 Office E&M - Established | Office | 18 | 16 | $22.71 | $409 |
| 99205 Office E&M - New | Office | 14 | 14 | $151.66 | $2,123 |
By year: 2022 $137K for 10,904 services; 2023 $83K for 9,147 services; 2024 $68K for 9,276 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sanjay K Juneja prescribed most often to Medicare patients was Pantoprazole Sodium, with 39 prescriptions and refills. In total Sanjay K Juneja wrote 630 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 39 | 90 | 19 | $811 |
| Prednisone Generic | 31 | 39 | 19 | $318 |
| Eliquis Apixaban | 27 | 43 | Under 11 | $25K |
| Xtandi Enzalutamide | 25 | 25 | Under 11 | $362K |
| Lenalidomide Generic | 24 | 24 | Under 11 | $286K |
| Revlimid Lenalidomide | 23 | 23 | Under 11 | $295K |
| Abiraterone Acetate Generic | 22 | 22 | Under 11 | $115K |
| Hydroxyurea Generic | 21 | 41 | Under 11 | $323 |
| Xarelto Rivaroxaban | 21 | 53 | Under 11 | $29K |
| Allopurinol Generic | 19 | 31 | Under 11 | $393 |
| Promethazine Hcl Generic | 19 | 19 | Under 11 | $121 |
| Pomalyst Pomalidomide | 17 | 17 | Under 11 | $382K |
| Tamoxifen Citrate Generic | 17 | 51 | Under 11 | $276 |
| Citalopram Hbr Citalopram Hydrobromide | 14 | 30 | Under 11 | $50.61 |
| Dexamethasone Generic | 14 | 34 | Under 11 | $560 |
Brand drugs: 190 claims; generic drugs: 440 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sanjay K Juneja $43K ($43K in general payments such as food, travel and fees) from 3 companies. The largest payer was Incyte Corporation with $43K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.